Serum endocan levels in endometrial and ovarian cancers

The use of novel technology-based weight loss interventions for obese women with endometrial hyperplasia and cancer

(2016) Ashley F. Haggerty et al.   GYNECOLOGIC ONCOLOGY

Endocan Elicits Severe Vascular Inflammatory Responses In Vitro and In Vivo

(2014) Wonhwa Lee et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Endocan, a new invasion and angiogenesis marker of pituitary adenomas

(2014) Fumihiro Matano et al.   JOURNAL OF NEURO-ONCOLOGY

Endocan is useful biomarker of survival and severity in sepsis

(2014) Dunja M. Mihajlovic et al.   MICROVASCULAR RESEARCH

Diagnostic value of serum HE4 in endometrial cancer: a meta-analysis

(2014) Yachun Bie et al.   World Journal of Surgical Oncology

Clinicopathological correlation of endocan expression and survival in epithelial ovarian cancer

(2013) Manal M. El Behery et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

Expression and significance of biglycan in endometrial cancer

(2013) Yang Liu et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

Serum Proteoglycans as Prognostic Biomarkers of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis

(2013) J.-C. Nault et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Microscopic lesions of fallopian tubes in endometrioid carcinoma of the endometrium: How effective are the macroscopic tubal sampling techniques?

(2013) Ibrahim Kulac et al.   Journal of Gynecologic Oncology

Endocan measurement for the postmortem diagnosis of sepsis

(2013) Cristian Palmiere et al.   Legal Medicine

Biomarkers for Screening, Diagnosis, and Monitoring of Ovarian Cancer

(2012) E. Kobayashi et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Endocan Is Upregulated on Tumor Vessels in Invasive Bladder Cancer Where It Mediates VEGF-A-Induced Angiogenesis

(2012) F. Roudnicky et al.   CANCER RESEARCH

Preoperative serum CA 125 level in the prediction of the stage of disease in endometrial carcinoma

(2012) Askin Yildiz et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders

(2011) Richard G. Moore et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Expression and distribution of endocan in human tissues

(2011) SM Zhang et al.   BIOTECHNIC & HISTOCHEMISTRY

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients

(2011) E Bignotti et al.   BRITISH JOURNAL OF CANCER

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer

(2011) Eleftheria Kalogera et al.   GYNECOLOGIC ONCOLOGY

CA 125 and the detection of recurrent ovarian cancer

(2010) Robert C. Bast   CANCER

Evaluation of serum CA-125 levels for preoperative counseling in endometrioid endometrial cancer: A multi-center study

(2010) Hee Seung Kim et al.   GYNECOLOGIC ONCOLOGY

Validation of serum biomarkers for detection of early- and late-stage endometrial cancer

(2009) Gina Farias-Eisner et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

HE4 as a biomarker for ovarian and endometrial cancer management

(2009) Jinping Li et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Vascular endocan (ESM-1) is markedly overexpressed in clear cell renal cell carcinoma

(2009) Xavier Leroy et al.   HISTOPATHOLOGY

Effect of Vascular Endothelial Growth Factor and Its Receptor Inhibitor on Proliferation and Invasion in Bladder Cancer

(2009) Ryoichi Nakanishi et al.   UROLOGIA INTERNATIONALIS

Transcriptional profiling of VEGF-A and VEGF-C target genes in lymphatic endothelium reveals endothelial-specific molecule-1 as a novel mediator of lymphangiogenesis

(2008) J. W. Shin et al.   BLOOD

Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus

(2008) Richard G. Moore et al.   GYNECOLOGIC ONCOLOGY